nodes	percent_of_prediction	percent_of_DWPC	metapath
Metolazone—Hypertensive—Octreotide—thymus cancer	0.217	0.217	CcSEcCtD
Metolazone—Abdominal bloating—Octreotide—thymus cancer	0.0526	0.0526	CcSEcCtD
Metolazone—Throat sore—Octreotide—thymus cancer	0.0347	0.0347	CcSEcCtD
Metolazone—Oropharyngeal discomfort—Octreotide—thymus cancer	0.0344	0.0344	CcSEcCtD
Metolazone—Petechiae—Octreotide—thymus cancer	0.0304	0.0304	CcSEcCtD
Metolazone—Jaundice cholestatic—Octreotide—thymus cancer	0.0285	0.0285	CcSEcCtD
Metolazone—Oropharyngeal pain—Octreotide—thymus cancer	0.0275	0.0275	CcSEcCtD
Metolazone—Neuropathy—Octreotide—thymus cancer	0.0235	0.0235	CcSEcCtD
Metolazone—Dry skin—Octreotide—thymus cancer	0.0167	0.0167	CcSEcCtD
Metolazone—Cramp muscle—Octreotide—thymus cancer	0.0164	0.0164	CcSEcCtD
Metolazone—Abdominal distension—Octreotide—thymus cancer	0.0158	0.0158	CcSEcCtD
Metolazone—Pancreatitis—Octreotide—thymus cancer	0.0154	0.0154	CcSEcCtD
Metolazone—Abdominal discomfort—Octreotide—thymus cancer	0.0151	0.0151	CcSEcCtD
Metolazone—Hyperglycaemia—Octreotide—thymus cancer	0.0142	0.0142	CcSEcCtD
Metolazone—Drowsiness—Octreotide—thymus cancer	0.014	0.014	CcSEcCtD
Metolazone—Neuropathy peripheral—Octreotide—thymus cancer	0.0137	0.0137	CcSEcCtD
Metolazone—Epistaxis—Octreotide—thymus cancer	0.0132	0.0132	CcSEcCtD
Metolazone—Hepatitis—Octreotide—thymus cancer	0.0126	0.0126	CcSEcCtD
Metolazone—Tinnitus—Octreotide—thymus cancer	0.0117	0.0117	CcSEcCtD
Metolazone—Flatulence—Octreotide—thymus cancer	0.0108	0.0108	CcSEcCtD
Metolazone—Tension—Octreotide—thymus cancer	0.0107	0.0107	CcSEcCtD
Metolazone—Nervousness—Octreotide—thymus cancer	0.0106	0.0106	CcSEcCtD
Metolazone—Back pain—Octreotide—thymus cancer	0.0106	0.0106	CcSEcCtD
Metolazone—Muscle spasms—Octreotide—thymus cancer	0.0105	0.0105	CcSEcCtD
Metolazone—Vision blurred—Octreotide—thymus cancer	0.0103	0.0103	CcSEcCtD
Metolazone—Ill-defined disorder—Octreotide—thymus cancer	0.0102	0.0102	CcSEcCtD
Metolazone—Anaemia—Octreotide—thymus cancer	0.0101	0.0101	CcSEcCtD
Metolazone—Agitation—Octreotide—thymus cancer	0.0101	0.0101	CcSEcCtD
Metolazone—Malaise—Octreotide—thymus cancer	0.00987	0.00987	CcSEcCtD
Metolazone—Vertigo—Octreotide—thymus cancer	0.00983	0.00983	CcSEcCtD
Metolazone—Syncope—Octreotide—thymus cancer	0.00981	0.00981	CcSEcCtD
Metolazone—Palpitations—Octreotide—thymus cancer	0.00967	0.00967	CcSEcCtD
Metolazone—Loss of consciousness—Octreotide—thymus cancer	0.00962	0.00962	CcSEcCtD
Metolazone—Cough—Octreotide—thymus cancer	0.00955	0.00955	CcSEcCtD
Metolazone—Hypertension—Octreotide—thymus cancer	0.00945	0.00945	CcSEcCtD
Metolazone—Arthralgia—Octreotide—thymus cancer	0.00932	0.00932	CcSEcCtD
Metolazone—Chest pain—Octreotide—thymus cancer	0.00932	0.00932	CcSEcCtD
Metolazone—Anxiety—Octreotide—thymus cancer	0.00928	0.00928	CcSEcCtD
Metolazone—Discomfort—Octreotide—thymus cancer	0.0092	0.0092	CcSEcCtD
Metolazone—Dry mouth—Octreotide—thymus cancer	0.00911	0.00911	CcSEcCtD
Metolazone—Shock—Octreotide—thymus cancer	0.00879	0.00879	CcSEcCtD
Metolazone—Thrombocytopenia—Octreotide—thymus cancer	0.00874	0.00874	CcSEcCtD
Metolazone—Anorexia—Octreotide—thymus cancer	0.00851	0.00851	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00814	0.00814	CcSEcCtD
Metolazone—Insomnia—Octreotide—thymus cancer	0.00808	0.00808	CcSEcCtD
Metolazone—Paraesthesia—Octreotide—thymus cancer	0.00802	0.00802	CcSEcCtD
Metolazone—Somnolence—Octreotide—thymus cancer	0.00794	0.00794	CcSEcCtD
Metolazone—Dyspepsia—Octreotide—thymus cancer	0.00786	0.00786	CcSEcCtD
Metolazone—Decreased appetite—Octreotide—thymus cancer	0.00776	0.00776	CcSEcCtD
Metolazone—Fatigue—Octreotide—thymus cancer	0.0077	0.0077	CcSEcCtD
Metolazone—Pain—Octreotide—thymus cancer	0.00764	0.00764	CcSEcCtD
Metolazone—Constipation—Octreotide—thymus cancer	0.00764	0.00764	CcSEcCtD
Metolazone—Feeling abnormal—Octreotide—thymus cancer	0.00736	0.00736	CcSEcCtD
Metolazone—Gastrointestinal pain—Octreotide—thymus cancer	0.0073	0.0073	CcSEcCtD
Metolazone—Urticaria—Octreotide—thymus cancer	0.00709	0.00709	CcSEcCtD
Metolazone—Abdominal pain—Octreotide—thymus cancer	0.00706	0.00706	CcSEcCtD
Metolazone—Hypersensitivity—Octreotide—thymus cancer	0.00658	0.00658	CcSEcCtD
Metolazone—Asthenia—Octreotide—thymus cancer	0.00641	0.00641	CcSEcCtD
Metolazone—Pruritus—Octreotide—thymus cancer	0.00632	0.00632	CcSEcCtD
Metolazone—Diarrhoea—Octreotide—thymus cancer	0.00611	0.00611	CcSEcCtD
Metolazone—Dizziness—Octreotide—thymus cancer	0.00591	0.00591	CcSEcCtD
Metolazone—Vomiting—Octreotide—thymus cancer	0.00568	0.00568	CcSEcCtD
Metolazone—Rash—Octreotide—thymus cancer	0.00563	0.00563	CcSEcCtD
Metolazone—Dermatitis—Octreotide—thymus cancer	0.00563	0.00563	CcSEcCtD
Metolazone—Headache—Octreotide—thymus cancer	0.00559	0.00559	CcSEcCtD
Metolazone—Nausea—Octreotide—thymus cancer	0.0053	0.0053	CcSEcCtD
